会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Combination therapy for treating cyclooxygenase-2 mediated diseases in patients at risk of thrombotic cardiovascular events
    • 在血栓性心血管事件危险的患者中治疗环氧合酶-2介导的疾病的组合疗法
    • US20050215611A1
    • 2005-09-29
    • US10513085
    • 2003-05-09
    • Richard HuntThomas Simon
    • Richard HuntThomas Simon
    • A61K31/415
    • A61K31/415
    • The present invention encompasses a method for treating a chronic cyclooxygenase-2 mediated disease or condition and reducing the risk of a thrombotic cardiovascular event in a human patient in need of such treatment and at risk of a thrombotic cardiovascular event comprising orally concomitantly or sequentially administering to said patient a cyclooxygenase-2 selective inhibitor in an amount effective to treat the cyclooxygenase-2 mediated disease or condition and nitric oxide releasing aspirin in an amount effective to reduce the risk of the thrombotic cardiovascular event while maintaining a high level of upper gastrointestinal safety and tolerability. The invention also encompasses a method for treating a chronic cyclooxygenase-2 mediated disease or condition and reducing the risk of a thrombotic cardiovascular event in a human patient in need of such treatment and at risk of a thrombotic cardiovascular event comprising orally concomitantly or sequentially administering to said patient a nitric oxide releasing-cyclooxygenase-2 selective inhibitor in an amount effective to treat the cyclooxygenase-2 mediated disease or condition and aspirin in an amount effective to reduce the risk of the thrombotic cardiovascular event while maintaining a high level of upper gastrointestinal safety and tolerability. Pharmaceutical compositions are also encompassed.
    • 本发明包括一种治疗慢性环氧合酶-2介导的疾病或病症并减少需要这种治疗的人类患者血栓性心血管事件的风险并且具有血栓性心血管事件的风险的方法,包括口服伴随地或依次给予 所述患者以有效治疗环氧合酶-2介导的疾病或病症和一氧化氮释放阿司匹林的量的环氧合酶-2选择性抑制剂的量有效降低血栓形成心血管事件的风险,同时保持高水平的上消化道安全性, 耐受性 本发明还包括一种治疗慢性环氧合酶-2介导的疾病或病症并降低需要这种治疗的人类患者血栓性心血管事件的风险并且具有血栓性心血管事件的风险的方法,其包括口服同时或依次给予 所述患者以有效治疗环氧合酶-2介导的疾病或病症和阿司匹林的量的一氧化氮释放 - 环氧合酶-2选择性抑制剂,其量可有效降低血栓形成心血管事件的风险,同时保持高水平的上消化道安全性 和耐受性。 也包括药物组合物。
    • 5. 发明申请
    • Air conditioning system
    • 空调系统
    • US20050166629A1
    • 2005-08-04
    • US10874025
    • 2004-06-22
    • Richard AxeRichard Hunt
    • Richard AxeRichard Hunt
    • B64D13/06F25B9/00F28B9/00F25D9/00F25D17/04
    • F25B9/004B64D13/06B64D2013/0688Y02T50/56
    • An air cycle air conditioning system for conditioning recirculating air from an enclosure includes an enclosure air recirculation loop, a first expansion turbine to which hot pressurized working air is provided, a heat exchanger to which a proportion of the hot pressurized working air is provided, from upstream of the first expansion turbine, and in which heat is exchanged to the cooler expanded air from the first expansion turbine. The working air from the heat exchanger expanded by the first expansion turbine and the cooled pressurized working air from the heat exchanger are combined prior to feeding the combined flows to a second expansion turbine. The system including a mixing apparatus in which the recirculating enclosure air from the loop and the cooled combined working air flows from the second expansion turbine are mixed prior to being provided to the enclosure.
    • 用于调节来自外壳的再循环空气的空气循环空调系统包括外壳空气再循环回路,设置热加压工作空气的第一膨胀涡轮机,设置有一部分热加压工作空气的热交换器, 在第一膨胀涡轮机的上游,并且其中热量从第一膨胀涡轮机更换到较冷的膨胀空气。 来自热交换器的工作空气由第一膨胀涡轮机膨胀,并且来自热交换器的冷却的加压工作空气在将组合流供给到第二膨胀涡轮机之前组合。 包括混合装置的系统在其被提供到外壳之前被混合,在该混合装置中将来自环路的再循环外壳和冷却的组合工作空气从第二膨胀涡轮流出。